- Home
- BSL vs RPTX Comparison
BSL vs RPTX Comparison
Compare BSL & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSL
- RPTX
- Stock Information
- Founded
- BSL 2010
- RPTX 2016
- Country
- BSL United States
- RPTX Canada
- Employees
- BSL N/A
- RPTX N/A
- Industry
- BSL Trusts Except Educational Religious and Charitable
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- BSL Finance
- RPTX Health Care
- Exchange
- BSL Nasdaq
- RPTX Nasdaq
- Market Cap
- BSL 183.2M
- RPTX 152.4M
- IPO Year
- BSL N/A
- RPTX 2020
- Fundamental
- Price
- BSL $14.42
- RPTX $2.97
- Analyst Decision
- BSL
- RPTX Strong Buy
- Analyst Count
- BSL 0
- RPTX 1
- Target Price
- BSL N/A
- RPTX $10.00
- AVG Volume (30 Days)
- BSL 71.9K
- RPTX 113.0K
- Earning Date
- BSL 01-01-0001
- RPTX 11-07-2024
- Dividend Yield
- BSL 9.55%
- RPTX N/A
- EPS Growth
- BSL N/A
- RPTX N/A
- EPS
- BSL N/A
- RPTX N/A
- Revenue
- BSL N/A
- RPTX $66,524,000.00
- Revenue This Year
- BSL N/A
- RPTX $13.36
- Revenue Next Year
- BSL N/A
- RPTX N/A
- P/E Ratio
- BSL N/A
- RPTX N/A
- Revenue Growth
- BSL N/A
- RPTX 18.19
- 52 Week Low
- BSL $12.19
- RPTX $2.71
- 52 Week High
- BSL $14.56
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- BSL 56.66
- RPTX 39.57
- Support Level
- BSL $14.14
- RPTX $2.81
- Resistance Level
- BSL $14.60
- RPTX $4.05
- Average True Range (ATR)
- BSL 0.15
- RPTX 0.27
- MACD
- BSL 0.03
- RPTX -0.08
- Stochastic Oscillator
- BSL 63.27
- RPTX 16.92
About BSL Blackstone Senior Floating Rate 2027 Term Fund of Beneficial Interest
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage, which may increase the risk to the Fund.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.